Micrometastasis, molecular markers, and their future role with EUS-guided FNA

Gastrointestinal Endoscopy

Volumn 69, Issue 2 SUPPL., 2009, Pages

  Wallace, Michael B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB;

ASPIRATION BIOPSY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MICROMETASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

BIOPSY, FINE-NEEDLE; ENDOSONOGRAPHY; FORECASTING; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 58549084218     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.12.040     Document Type: Review

References (16)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Wallace M.B., Silvestri G.A., Sahai A.V., et al. Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann Thorac Surg 72 (2001) 1861-1867
3. Wallace M.B., Block M.I., Gillanders W., et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 127 (2005) 430-437
4. Wallace M.B., Block M., Hoffman B.J., et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med 167 (2003) 1670-1675
5. Potti A., Mukherjee S., Petersen R., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355 (2006) 570-580
6. Nicholson R.I., Gee J.M., and Harper M.E. EGFR and cancer prognosis. Eur J Cancer 37 Suppl 4 (2001) S9-S15
7. Sridhar S.S., Seymour L., and Shepherd F.A. Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. Lancet Oncol 4 (2003) 397-406
8. Kim K.-S., Jeong J.-Y., Kim Y.-C., et al. Predictors of the response to gefitinib in refractory non-small cell lung cancer. Clin Cancer Res 11 (2005) 2244-2251
9. Tsao M.-S., Sakurada A., Cutz J.-C., et al. Erlotinib in lung cancer: molecular and clinical predictors of outcome. N Engl J Med 353 (2005) 133-144
10. Brugge W.R., Lauwers G.Y., Sahani D., et al. Cystic neoplasms of the pancreas. N Engl J Med 351 (2004) 1218-1226
11. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126 (2004) 1330-1336
12. Khalid A., McGrath K.M., Zahid M., et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 3 (2005) 967-973
13. Pellise M., Castells A., Gines A., et al. Clinical usefulness of KRAS mutational analysis in the diagnosis of pancreatic adenocarcinoma by means of endosonography-guided fine-needle aspiration biopsy. Aliment Pharmacol Ther 17 (2003) 1299-1307
14. Khalid A., Zahid L., Bauer K., et al. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 101 (2006) 2493-2500
15. Levy M.J., Baron T.H., Clayton A.C., et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 103 (2008) 1263-1273
16. Pellise M., Castells A., Gines A., et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography- guided fine-needle aspiration biopsy. Clin Cancer Res 10 (2004) 4444-4449